Trials / Unknown
UnknownNCT02011659
Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy
A Randomized Prospective Study of Scheduled Intravenous Ramosetron for the Prevention of Nausea and Vomiting in Hospitalized Patients After Gynecologic Laparoscopy
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 128 (estimated)
- Sponsor
- National Health Insurance Service Ilsan Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To compare postoperative nausea and vomiting (PONV) and perioperative outcomes of gynecologic patients undergoing laparoscopic surgery after scheduled administration of intravenous Ramosetron during hospital stays. * Randomized controlled arm : Placebo versus Ramosetron injection * Administration schedule : immediate postoperative status, 12 hrs after surgery, 36hrs after surgery
Detailed description
Surgical outcomes including operative time, blood loss, Hb change, postoperative pain, nausea/vomiting scale, times of rescue therapy, and complications
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ramosetron |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2015-11-01
- First posted
- 2013-12-13
- Last updated
- 2013-12-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02011659. Inclusion in this directory is not an endorsement.